1. Home
  2. TLSA vs VIGL Comparison

TLSA vs VIGL Comparison

Compare TLSA & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • VIGL
  • Stock Information
  • Founded
  • TLSA 2013
  • VIGL 2020
  • Country
  • TLSA United Kingdom
  • VIGL United States
  • Employees
  • TLSA N/A
  • VIGL N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • VIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • TLSA Health Care
  • VIGL Health Care
  • Exchange
  • TLSA Nasdaq
  • VIGL Nasdaq
  • Market Cap
  • TLSA 87.8M
  • VIGL 89.3M
  • IPO Year
  • TLSA 2000
  • VIGL 2022
  • Fundamental
  • Price
  • TLSA $0.66
  • VIGL $2.73
  • Analyst Decision
  • TLSA
  • VIGL Strong Buy
  • Analyst Count
  • TLSA 0
  • VIGL 5
  • Target Price
  • TLSA N/A
  • VIGL $21.00
  • AVG Volume (30 Days)
  • TLSA 1.2M
  • VIGL 2.6M
  • Earning Date
  • TLSA 02-11-2025
  • VIGL 03-25-2025
  • Dividend Yield
  • TLSA N/A
  • VIGL N/A
  • EPS Growth
  • TLSA N/A
  • VIGL N/A
  • EPS
  • TLSA N/A
  • VIGL N/A
  • Revenue
  • TLSA N/A
  • VIGL N/A
  • Revenue This Year
  • TLSA N/A
  • VIGL N/A
  • Revenue Next Year
  • TLSA N/A
  • VIGL N/A
  • P/E Ratio
  • TLSA N/A
  • VIGL N/A
  • Revenue Growth
  • TLSA N/A
  • VIGL N/A
  • 52 Week Low
  • TLSA $0.41
  • VIGL $1.49
  • 52 Week High
  • TLSA $1.74
  • VIGL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 39.85
  • VIGL 71.47
  • Support Level
  • TLSA $0.65
  • VIGL $2.22
  • Resistance Level
  • TLSA $0.70
  • VIGL $2.53
  • Average True Range (ATR)
  • TLSA 0.08
  • VIGL 0.29
  • MACD
  • TLSA -0.01
  • VIGL 0.08
  • Stochastic Oscillator
  • TLSA 6.45
  • VIGL 81.82

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.

Share on Social Networks: